-
公开(公告)号：KR1020070121239A
公开(公告)日：2007-12-27
申请号：KR1020060056032
申请日：2006-06-21
Applicant: (주)아모레퍼시픽
CPC classification number: A61K8/987 , A61K8/97 , A61Q19/007
Abstract: A cosmetic composition comprising the extracts of honey and pumpkin is provided to prevent and improve symptoms of the skin caused by water deficiency safely by containing a large quantity of water in a horny layer and reducing water evaporation from the horny layer. A cosmetic composition for moisturizing the skin comprises honey extract containing mono-saccharides including glucose and fructose having strong moisturizing effects and pumpkin extract containing vitamins, especially vitamin A and C and minerals having strong anti-oxidative, skin-restoring and skin-protecting effects, and optionally comprises polyol selected from glycerin, dipropylene glycol, propylene glycol, 1,3-butylene glycol and polyethylene glycol.
Abstract translation: 提供包含蜂蜜和南瓜提取物的化妆品组合物，通过在角质层中含有大量水并减少水分从角质层蒸发而安全地防止并改善由缺水引起的皮肤症状。 用于保湿皮肤的化妆品组合物包含含有包含具有强保湿作用的葡萄糖和果糖的单糖的蜂蜜提取物和含有维生素，特别是维生素A和C的南瓜提取物以及具有强抗氧化，皮肤恢复和皮肤保护作用的矿物质， 并且任选地包含选自甘油，二丙二醇，丙二醇，1,3-丁二醇和聚乙二醇的多元醇。
-
公开(公告)号：KR100787328B1
公开(公告)日：2007-12-18
申请号：KR1020060042420
申请日：2006-05-11
Applicant: (주)아모레퍼시픽
CPC classification number: A61K8/11 , A61K8/342 , A61K8/375 , A61K8/671 , A61K2800/52 , A61Q19/00 , A61Q19/08
Abstract: 본 발명은 마크로 크기(0.01 내지 5mm)의 지질 캡슐 입자를 갖는 에멀젼 조성물 및 이를 이용한 피부 화장료 조성물에 관한 것으로, 보다 상세하게는 액상 오일과 외피 지질(Lipid) 또는 리포이드(Lipoid)의 조합을 이용하여 입자의 크기를 조절하고 액상 오일을 외피 지질로 캡슐화함으로써, 큰 입자크기에도 불구하고 안정도가 향상된 에멀젼 조성물에 관한 것이다. 본 발명에 의한 에멀젼 조성물은 눈으로 식별 가능할 정도의 큰 입자 크기로 인해 독특한 외관 및 사용감을 가지고, 계면활성제를 사용하지 않아도 안정한 에멀젼을 얻을 수 있어 무계면활성제 시스템으로 인한 피부 안전성 및 보습 지속성이 우수하며, 산화되기 쉬운 친유성 효능 성분의 활성을 장기간 유지시켜 줌으로써 화장료로서의 새로운 가치를 부여하는 것을 특징으로 한다.
지질, 캡슐, 에멀젼, 안정도, 거대 입자, 계면활성제-
公开(公告)号：KR1020070106175A
公开(公告)日：2007-11-01
申请号：KR1020060038746
申请日：2006-04-28
Applicant: (주)아모레퍼시픽
CPC classification number: A61K8/97 , A61K36/48 , A61K36/752 , A61K36/82 , A61Q17/00 , A61Q19/08 , Y10S514/844
Abstract: A cosmetic composition containing plant extracts is provided to improve effects of skin moisturizing and skin elasticity by removing free radicals and increasing activity of protection factors in the skin with plentiful amounts of catechin, vitamin C and tocopherol in the plant extracts. A cosmetic composition contains 0.01-30.00 wt.%, preferably 0.1-20.00 wt.% of plant extracts(SATIN complex) including green tea extract, tangerine extract and soybean extract in a weight ratio of 1:1:1 to 10:1:1, and is formulated as soft lotion, nutrition lotion, massage cream, nutrition cream, pack, gel or skin adhesive type cosmetics.
Abstract translation: 提供含有植物提取物的化妆品组合物，通过去除植物提取物中大量的儿茶素，维生素C和维生素E，去除自由基并增加皮肤中保护因子的活性，从而改善皮肤保湿和皮肤弹性的作用。 化妆品组合物含有重量比为1：1：1至10：1的植物提取物（SATIN复合物），包括绿茶提取物，橘子提取物和大豆提取物的0.01-30.00重量％，优选0.1-20.00重量％ 1，配方为柔软乳液，营养乳液，按摩霜，营养霜，包装，凝胶或皮肤粘合型化妆品。
-
公开(公告)号：KR1020050048259A
公开(公告)日：2005-05-24
申请号：KR1020030082144
申请日：2003-11-19
Applicant: (주)아모레퍼시픽
CPC classification number: A61Q19/02 , A61K8/4986 , A61K8/97 , A61K2800/70
Abstract: 본 발명은 멜라닌 합성경로를 조절하여 멜라닌 과다 생성 억제; 멜라닌 색소의 조절; 및 멜라닌 배출 촉진;의 3단계로 미백작용을 하는 피부 미백 화장료 조성물에 관한 것이다. 더욱 상세하게는, 본 발명의 피부 미백 화장료 조성물은 멜라닌 과다 생성 억제 미백기능과 동시에 멜라닌 색소 조절 미백기능을 하는 EPS 복합체 및 멜라닌 배출촉진제로서 각질제거제를 함유하여 우수한 미백효과를 나타낸다.
-
245.发明公开나노유화기술에 의해 20-0-[α-Ｌ-아라비노피라노실(1-〉6)-β-Ｄ-글루코피라노실]-20(Ｓ)-프로토파낙사다이올을 함유하는 미세 유화 입자 및 이를 사용한 피부 외용제 조성물 有权含有20-0- [α-氨基阿维菌素（1-> 6）-β-D-吡喃葡萄糖苷] -20（S） - 丙酸酰胺的微乳液颗粒和使用其的皮肤外用制剂组合物
公开(公告)号：KR1020030080429A
公开(公告)日：2003-10-17
申请号：KR1020020019032
申请日：2002-04-08
Applicant: (주)아모레퍼시픽
Abstract: PURPOSE: A microemulsion particle containing 20-0-£α-L-arabinopyranosyl(1->6)-β-D-glucopyranosyl|-20(S)-protopanaxadiol separated from bioconversion of ginseng saponin is provided. The external preparation composition of skin using the same has an excellent effect of preventing skin aging, such as wrinkle improvement. CONSTITUTION: The microemulsion particle contains 10¬-8 to 99.9999% by weight of 20-0-£α-L-arabinopyranosyl(1->6)-β-D-glucopyranosyl|-20(S)-protopanaxadiol of the formula 1 as an effective ingredient and liposome containing lecithin, lecithin derivatives and a co-emulsifier, based on the total weight of the particle. In formula, R2 is OH and R3 is H. The microemulsion particle is prepared from acid hydrolysis, base hydrolysis or enzymolysis of ginseng extract and ginseng saponin. The cosmetic and pharmaceutical composition having excellent effects of proliferating skin cells and promoting collagen biosynthesis is obtained by formulation of the microemulsion particle.
Abstract translation: 目的：提供从人参皂角苷生物转化分离的含有20-0-α-L-阿拉伯吡喃糖基（1-> 6）-β-D-吡喃葡萄糖基| -20（S） - 原人参二醇的微乳液颗粒。 使用其的皮肤外用制剂组合物具有防止皮肤老化的良好效果，例如皱纹改善。 构成：微乳液颗粒含有10-80-99.9999重量％的式1的20-0-α-L-阿拉伯吡喃糖基（1-> 6）-β-D-吡喃葡萄糖基| -20（S） - 原人参二醇 作为含有卵磷脂，卵磷脂衍生物和辅助乳化剂的有效成分和脂质体，基于颗粒的总重量。 在式中，R2为OH，R3为H.微乳液颗粒由人参皂苷和人参皂苷的酸水解，碱水解或酶解制备。 通过配制微乳液颗粒获得具有增强皮肤细胞和促进胶原合成的优异效果的化妆品和药物组合物。
-
Patent Agency Ranking246.发明公开액정 배열 안정화 시스템(ＬＡＳＳ)을 이용한 유용성활성물질 안정화 열방성 액정 마이크로 캡슐의 제조방법및 이를 함유하는 화장료 조성물 有权使用液晶相关稳定系统（LASS）稳定水不溶性活性成分的热成型液晶微球，其制备方法和COSM
公开(公告)号：KR1020030071312A
公开(公告)日：2003-09-03
申请号：KR1020020010961
申请日：2002-02-28
Applicant: (주)아모레퍼시픽
IPC: B01J13/14
CPC classification number: B01J13/14 , A61K8/0295 , A61K8/11 , A61K8/347 , A61K8/355 , A61K8/67 , A61K2800/412
Abstract: PURPOSE: Liquid crystal cross linked polymer microcapsules capable of completely stabilizing water-insoluble active ingredients, a process for preparing the capsules, a method for stabilizing the active ingredients using the liquid crystal capsules, and a cosmetic composition for retaining the active ingredients for a long time by containing the microcapsules are provided. CONSTITUTION: The process for preparing liquid crystal cross linked polymer microcapsules comprises a step (a) of polymerizing polymer having crosslinkable functional groups by polymerizing monomer having crosslinkable functional groups and monomer capable of radical polymerization; a step (b) of uniformly dissolving thermotropic liquid crystal, hydrophobic monomer and the polymer having crosslinkable functional groups prepared in the step (a) into organic solvent, emulsifying the solution in an aqueous solution in which dispersion stabilizer having a proper concentration is dissolved, and adding initiator and polymerization inhibitor to the emulsified solution, thereby polymerizing the emulsified solution so that thermotropic liquid crystal polymer microcapsules are manufactured; a step (c) of collecting water-insoluble active ingredients into the capsules; and a step (d) of cross linking the water-insoluble active ingredients collected liquid crystal polymer microcapsules, wherein 0.1 to 50 wt.% of the monomer having crosslinkable functional groups for the total weight of the polymer is used in the step (a) of polymerizing polymer having crosslinkable functional groups.
Abstract translation: 目的：能够完全稳定水不溶性活性成分的液晶交联聚合物微胶囊，制备胶囊的方法，使用液晶胶囊稳定活性成分的方法和用于保持活性成分长时间的化妆品组合物 提供含有微胶囊的时间。 构成：制备液晶交联聚合物微胶囊的方法包括通过聚合具有可交联官能团的单体和能够进行自由基聚合的单体聚合具有可交联官能团的聚合物的步骤（a） 将热致液晶，疏水性单体和在步骤（a）中制备的具有交联性官能团的聚合物）均匀溶解于有机溶剂中的步骤（b），将其溶解于溶解有适当浓度的分散稳定剂的水溶液中乳化， 并向乳化溶液中加入引发剂和聚合抑制剂，从而使乳化溶液聚合，从而制得热致液晶聚合物微胶囊; 将水不溶性活性成分收集到胶囊中的步骤（c）; 和交联水溶性活性成分收集的液晶聚合物微胶囊的步骤（d），其中在步骤（a）中使用0.1至50重量％的具有可交联官能团的聚合物总重量的单体， 的具有可交联官能团的聚合物。
-
公开(公告)号：KR1020020043840A
公开(公告)日：2002-06-12
申请号：KR1020000072981
申请日：2000-12-04
Applicant: (주)아모레퍼시픽
CPC classification number: A61K8/0208 , A61K8/361 , A61K8/671 , A61K8/676 , A61K2800/75 , A61K2800/87 , A61Q19/00 , A61Q19/08
Abstract: PURPOSE: A method for increasing the stability of a drug by using a semi-permeable film as a supporter of a transdermal administration type preparation, packing the preparation with packing paper of a multilayer film and filling nitrogen is provided. Whereby, the transdermal absorption type pharmaceutical preparation can reduce irritation on the skin or discomfort. CONSTITUTION: The transdermal administration type preparation comprises a supporter, an adhesive layer containing a drug having a wrinkle preventing or removing effect and a release film to stabilize the drug and reduce skin irritation in a transdermal administration type preparation containing a retinoid-based drug, wherein a semi-permeable film is used as a supporter of the transdermal administration type preparation, the transdermal administration type preparation is packed with packing paper of a multilayer film and nitrogen is filled at the same time.
Abstract translation: 目的：提供通过使用半透膜作为透皮给药型制剂的载体来提高药物的稳定性的方法，用多层膜的填充纸填充制剂并填充氮气。 因此，经皮吸收型药物制剂可以减少对皮肤的刺激或不适。 构成：透皮给药型制剂包含支持体，含有防皱或去皱效果的药物的粘合剂层和稳定药物的脱模膜，并减少含有类视黄醇类药物的透皮给药型制剂中的皮肤刺激性，其中 使用半透膜作为透皮给药型制剂的载体，透皮给药型制剂用多层膜的包装纸填充，同时填充氮气。
-
-
-
-
-
-
-
Search Results
419
records
(took 0.064 seconds)
